News | Cardiovascular Ultrasound | June 16, 2017

Disparities Found in Standard of Cardiac Care for Heart Valve Disease in Minorities

heart valve regurgitation seen on an echocardiogram, cardiac ultrasound, from ASE study

June 15, 2017 – While much attention has been focused on ways to lower heart disease-related injuries and deaths, there is accumulating evidence that there is still much to be done for this work to reach all segments of the U.S. population. A group of researchers from Massachusetts General Hospital (MGH), looked at cardiovascular patient care during a 15-year time frame and found there remains significant disparities in routine cardiac care for chronic heart valve disease. Minorities, Hispanics in particular, continue to be less likely to receive timely and thorough cardiac ultrasound evaluations.  

Research led by Varsha K. Tanguturi, M.D., of MGH looked at more than 31,058 patient records and found that Hispanic patients were less likely to receive follow-up transthoracic echocardiograms (TTE) for their valve issues than would be considered appropriate by medical guidelines. 

“Looking at patient patterns from 2001-2016, our preliminary analysis shows there may be disparities in the receipt of surveillance imaging for mitral valve disease,” Tanguturi said. Researchers also found that as patients aged, the odds of having a TTE within the appropriate time interval decreased across all races.
 
Further research into other types of valvular disease in broader patient populations is needed to determine the extent and significance of these results. The cause of these disparities, whether from variability in ordering by the provider, or patient access to care is unknown. The clinical significance of these disparities is also yet to be determined, but identification of the causes could allow for interventions to improve the ability for at-risk patients to complete appropriate surveillance of valvular disease, which could in turn possibly improve cardiovascular health outcomes.   
 
Tanguturi will present a poster based on this research presented a poster based on this research during the recent American Society of Echocardiography (ASE) 2017 meeting. Additional researchers on the study “Disparities in Echocardiographic Surveillance of Mitral Regurgitation (MR),” include Vijeta Bhambhani, Michael Picard, M.D., Katrina Armstrong, M.D. and Jason Wasfy, M.D., MPhil.

Read the article "Race, Gender and Socioeconomic Factors Impact PCI Outcomes."
 

For more information: ASEcho.org

Related Content

Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound| October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
Videos | Cardiovascular Ultrasound| October 12, 2017
Sharon Mulvagh, M.D., FRCPC, FACC, FAHA, FASE, professor, Division of Cardiology, Department of Medicine, Dalhouse Un
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Toshiba Medical's Portable Ultrasound Used in Second Pediatric Mission in Tanzania
News | Ultrasound Imaging| October 05, 2017
October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Overlay Init